marketinsights

Unveiling the Future of COVID-19 Vaccines: Gritstone Bios’ Groundbreaking Presentation at IDWeek 2023

Presentations at IDWeek 2023 Highlight Potentially Differentiated Immunogenicity of Gritstone bio’s Next Generation COVID-19 Vaccine High neutralizing antibody (nAb) responses sustained through at least 12 months Gritstone bio’s next generation COVID-19 vaccine has shown promising results with high neutralizing antibody responses lasting for at least 12 months. This highlights the potential for durable clinical protection…

Read More

Meet the Dynamic Duo: Gravity Diagnostics’ Julie Brazil and Karen Hargett Nominated for Prestigious Cincinnati Business Courier C-Suite Awards in 2023!

Gravity Diagnostics’ Julie Brazil, COO, and Karen Hargett, CHRO, Nominated as Cincinnati Business Courier 2023 C-Suite Award Finalists Witty, Conversational, and Offbeat Leadership Takes Center Stage Covington, KY, Oct. 10, 2023 (GLOBE NEWSWIRE) — When you think of leadership, what comes to mind? Is it someone who commands the room with authority, or perhaps someone…

Read More

Protecting Biodiversity: Norton Rose Fulbright’s Partnership with Conservation International

Norton Rose Fulbright assists Conservation International in biodiversity protection Houston, TX, Oct. 09, 2023 (GLOBE NEWSWIRE) — Global law firm Norton Rose Fulbright announced today that it will partner with Conservation International, a nonprofit environmental organization working to protect forests, oceans and other living ecosystems, for its 2023 Global Charitable Initiative (GCI). This year’s GCI…

Read More

Take Action: Bragar Eagel & Squire P.C. Urges Investors to Reach Out Regarding Infinity Pharmaceuticals Inc. Class Action Lawsuit

Welcome to the World of Stockholder Rights Law Delving into the Class Action Lawsuit Against Infinity Pharmaceuticals, Inc. New York, Oct. 08, 2023 (Globe Newswire) – Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Infinity Pharmaceuticals, Inc. (“Infinity” or the…

Read More